Business Context and Reporting Period
Company: Mustang Bio, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 30, 2016
Event: Entry into a Material Definitive Agreement regarding board advisory services.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a specific contractual agreement.
Material Changes
The Board of Directors approved an Advisory Agreement with Caribe BioAdvisors, LLC, owned by Michael S. Weiss, the Chairman of the Board. The agreement, effective January 1, 2017, formalizes the provision of board advisory services by Mr. Weiss.
Guidance, Outlook, and Management Commentary
- Compensation Terms: The Advisor will receive an annual cash fee of $60,000.
- Equity Incentives: The cash fee is in addition to any annual equity incentive grants paid to members of the Board.
- Risks and Contingencies: The filing states that the summary is subject to and qualified in its entirety by the text of the Advisory Agreement.
Important Facts for Investor Verification
- Verify the full terms of the Advisory Agreement with Caribe BioAdvisors, LLC.
- Confirm the total annual compensation package for Michael S. Weiss, including the $60,000 cash fee and any equity grants.
- Review the effective date of the agreement (January 1, 2017) relative to the fiscal year.